Skip to main content

New River Pharmaceuticals

(NRPH)

has hired Garen Z. Manvelian, M.D., to serve as chief medical officer.

Manvelian will work from the company's laboratories at the Virginia Tech Corporate Research Center in Blacksburg, Va., and will report to COO and CFO, Krish S. Krishnan.

Manvelian joins New River from

TheStreet Recommends

SkyePharma

(SKYE)

, where he served since 2000 as senior director of clinical and medical affairs.

"I am excited about the promise of New River's current and future clinical projects and am eager to apply my experience to help advance the company's compounds toward regulatory approval," Manvelian said.

Shares of New River Pharma were up 17 cents, or 0.7%, at $24.95 in recent after-hours trading.